ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
0.088
0.006
( 7.32% )
更新日時: 09:22:36

Chimeric Therapeutics Limited (CHM) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.088
( 7.32% )
買値
0.082
売値
0.089
出来高
90,000
0.085 日の範囲 0.088
0.001 52 週間の範囲 0.20
時価総額
前日終値
0.082
始値
0.085
最終取引時間
09:22:06
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 121,805
発行済株式数
53,181,726
配当利回り
PER
-0.11
1 株当たり利益 (EPS)
-0.75
歳入
9.75M
純利益
-18.79M

Chimeric Therapeutics Limited について

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendoc... Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Carlton, Australia
設立
2026
Chimeric Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker CHM. The last closing price for Chimeric Therapeutics was AUD0.08. Over the last year, Chimeric Therapeutics shares have traded in a share price range of AUD 0.001 to AUD 0.20.

Chimeric Therapeutics currently has 53,181,726 shares in issue. The market capitalisation of Chimeric Therapeutics is AUD4.68 million. Chimeric Therapeutics has a price to earnings ratio (PE ratio) of -0.11.

CHM 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.012-120.10.140.0824176930.09790829DE
4-0.067-43.22580645160.1550.1550.0822125260.11074687DE
120.08643000.0020.20.00112556750.01321561DE
260.08421000.0040.20.00141347800.00403696DE
520.08316600.0050.20.00165626160.00357948DE
1560.0481200.040.20.00141041750.00957434DE
260-0.217-71.14754098360.3050.3750.00126636260.02554135DE

CHM - Frequently Asked Questions (FAQ)

What is the current Chimeric Therapeutics Limited share price?
The current share price of Chimeric Therapeutics Limited is AUD 0.088
How many Chimeric Therapeutics Limited shares are in issue?
Chimeric Therapeutics Limited has 53,181,726 shares in issue
What is the market cap of Chimeric Therapeutics Limited?
The market capitalisation of Chimeric Therapeutics Limited is AUD 4.68M
What is the 1 year trading range for Chimeric Therapeutics Limited share price?
Chimeric Therapeutics Limited has traded in the range of AUD 0.001 to AUD 0.20 during the past year
What is the PE ratio of Chimeric Therapeutics Limited?
The price to earnings ratio of Chimeric Therapeutics Limited is -0.11
What is the cash to sales ratio of Chimeric Therapeutics Limited?
The cash to sales ratio of Chimeric Therapeutics Limited is 0.45
What is the registered address of Chimeric Therapeutics Limited?
The registered address for Chimeric Therapeutics Limited is 62 Lygon Street, Carlton, Victoria, 3053
What is the Chimeric Therapeutics Limited website address?
The website address for Chimeric Therapeutics Limited is www.chimerictherapeutics.com
Which industry sector does Chimeric Therapeutics Limited operate in?
Chimeric Therapeutics Limited operates in the Biotechnology & Life Sciences sector

CHM 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock